| Viral hijacking of cellular metabolism SK Thaker, J Ch’ng, HR Christofk BMC biology 17, 1-15, 2019 | 466 | 2019 |
| Targeting nucleotide metabolism as the nexus of viral infections, cancer, and the immune response Y Ariav, JH Ch’ng, HR Christofk, N Ron-Harel, A Erez Science advances 7 (21), eabg6165, 2021 | 70 | 2021 |
| Monocarboxylate transporter antagonism reveals metabolic vulnerabilities of viral-driven lymphomas EN Bonglack, JE Messinger, JM Cable, J Ch’ng, KM Parnell, ... Proceedings of the National Academy of Sciences 118 (25), e2022495118, 2021 | 49 | 2021 |
| Structuring survivorship care: discipline-specific clinician perspectives EA Gage, M Pailler, MA Zevon, J Ch’ng, A Groman, M Kelly, C Panagakis, ... Journal of Cancer Survivorship 5, 217-225, 2011 | 47 | 2011 |
| Treatment of post‐transplant lymphoproliferative disorder (PTLD) in a heart transplant recipient with chimeric antigen receptor T‐cell therapy BN Dang, J Ch’ng, M Russell, JC Cheng, TB Moore, JC Alejos Pediatric Transplantation 25 (5), e13861, 2021 | 22 | 2021 |
| Recombinant human granulocyte-macrophage colony-stimulating factor (rhu GM-CSF) as adjuvant therapy for invasive fungal diseases TK Chen, JS Batra, DE Michalik, J Casillas, R Patel, ME Ruiz, H Hara, ... Open Forum Infectious Diseases 9 (11), ofac535, 2022 | 19 | 2022 |
| Targeting nucleotide metabolism as the nexus of viral infections, cancer, and the immune response. Sci Adv 7: eabg6165 Y Ariav, JH Ch’ng, HR Christofk, N Ron-Harel, A Erez | 8 | 2021 |
| HR Christofk Viral hijacking of cellular metabolism., 2019, 17, 59 SK Thaker, J Ch’ng DOI: https://doi. org/10.1186/s12915-019-0678-9, 0 | 8 | |
| Pediatric hematopoietic cell transplantation: longitudinal trends in body mass index and outcomes BN Dang, H Wilhalme, J Ch'ng, S De Oliveira, LV Bowles, TB Moore Pediatric Transplantation 24 (7), e13844, 2020 | 4 | 2020 |
| Epstein-Barr virus reactivation induces divergent abortive, reprogrammed, and host shutoff states by lytic progression ED SoRelle, LE Haynes, KA Willard, B Chang, J Ch’ng, H Christofk, ... PLoS Pathogens 20 (10), e1012341, 2024 | 1 | 2024 |
| CLINICAL MANIFESTATIONS OF HEMOPHAGOCYTIC LYMPHOHISTIOCYTOSIS ASSOCIATED WITH RARE DNASE2 VARIANT B Patel, M Kadapakkam, H Hara, M Ruiz, J Ch'Ng PEDIATRIC BLOOD & CANCER 69, 2022 | | 2022 |
| Successful Engraftment Utilizing a Non-Myeloablative Conditioning Regimen for Aplastic Anemia with Early Signs of Myelodysplastic Disease AN Gray, J Ch'ng, W May, JC Cheng, TB Moore 2021 TCT| Transplantation & Cellular Therapy Meetings of ASTCT and CIBMTR, 2021 | | 2021 |
| Targeting nucleotide metabolism as the nexus of viral infections, cancer, and the immune Y Ariav, JH Ch’ng, HR Christofk, Y Ariav, JH Ch’ng, HR Christofk, ... | | 2021 |
| A comparison of oncology clinicians' preferences for structuring survivorship care. E Gage, M Pailler, M Gruber, M Kelly, J Yasko, M Zevon, D Somayaji, ... Journal of Clinical Oncology 28 (15_suppl), e19545-e19545, 2010 | | 2010 |
